Design, Development and Characterization of Ketorolac Tromethamine Polymeric Nanosuspension

References

• Fathalla Z , VangalaA , LongmanMet al. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterization, toxicity and transcorneal permeation studies. Eur. J. Pharm. Biopharm.114, 119–134 (2017).
   PubMed Web of Science ®Google Scholar
• Das S , SureshPK , DesmukhR. Design of eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine6(2), 318–323 (2010).
   PubMed Web of Science ®Google Scholar
• Suresh S , AhujaBK , JenaSK , PaidiSK , BagriS. Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. Int. J. Pharm.478, 540–552 (2015).
   PubMedGoogle Scholar
• Shrivastava A , SakthivelS , PitchumaniB , RathoreAS. A statistical approach for estimation of significant variables in wet attrition milling. Powder Technol.211, 46–53 (2011).
   Web of Science ®Google Scholar
• Khalil RM , KassemMA , AbdelRahman AA , GhorabMM , AhmedMB. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int. J. Pharm.340, 126–133 (2007).
   PubMedGoogle Scholar
• Singla S , MajumdarDK , GoyalS , KhilnanicG. Evidence of carrier mediated transport of ascorbic acid through mammalian cornea. Saudi Pharm. J.19(3), 165–170 (2011).
   PubMed Web of Science ®Google Scholar
• Bhosale R , BhandwalkarO , DuduskarA , JadhavR , PawarP. Water soluble chitosan mediated voriconazole microemulsion as sustained carrier for ophthalmic application: in vitro/ex vivo/in vivo evaluations. Open Pharm. Sci. J.3, 215–234 (2016).
   Google Scholar
• Bucolo C , DragoF , SalomoneS. Ocular drug delivery: a clue from nanotechnology. Frontiers Pharmacol.3, 1–3 (2012).
   PubMed Web of Science ®Google Scholar
• Patel CM , ChakrabortyM , MurthyZVP. Preparation of fenofibrate nanoparticles by combined stirred media milling and ultrasonication method. Ultrason. Sonochem.21, 1100–1107 (2014).
   PubMed Web of Science ®Google Scholar
• Ying X , XuY , LuYet al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid–base neutralization. Int. J. Pharm.438, 287–295 (2012).
   PubMedGoogle Scholar
• Bucolo C , MalteseA , PuglisiG , PignatelloR. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an eudragit RS100 nanoparticle suspension. Ophthalmic Res.34, 319–323 (2002).
   PubMed Web of Science ®Google Scholar
• Pignatello R , BucoloC , FerraraP , MalteseA , PuleoA , PuglisiG. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci.16, 53–61 (2002).
   PubMed Web of Science ®Google Scholar
• Pignatello R , BucoloC , SpedalieriG , MalteseA , PuglisiG. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials23, 3247–3255 (2002).
   PubMed Web of Science ®Google Scholar
• Pignatello R , BucoloC , PuglisiG. Ocular tolerability of eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. J. Pharm. Sci.91(12), 2636–2641 (2002).
   PubMed Web of Science ®Google Scholar
• Bucolo C , MalteseA , MaugeriF , BusaB , PuglisiG , PignatelloR. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene. J. Pharmacy Pharmacol.56, 841–846 (2004).
   PubMed Web of Science ®Google Scholar
• Tang X , YangH , TengFet al. Investigation of nanosuspension stabilized by Soluplus to improve bioavailability. Int. J. Pharm.477, 88–95 (2014).
   PubMedGoogle Scholar
• Sahu BP , DasMK. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl. Nanosci.4, 189–197 (2014).
   Web of Science ®Google Scholar
• Pawar P , MudgilM. Preparation and in vitro/ex vivo evaluation of moxifloxacin-loaded PLGA nanosuspension for ophthalmic application. Sci. Pharm.81(2), 591–606 (2013).
   PubMedGoogle Scholar
• Choi JY , YooJY , KwakHS , NamBU , LeeJ. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Phys.5, 472–474 (2005).
   Web of Science ®Google Scholar
• Kakran M , SahooNG , LiLet al. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int. J. Pharm.383(1-2), 285–292 (2010).
   PubMedGoogle Scholar
• Das S , SureshPK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface: application to amphotericin B. Nanomedicine: Nanotech. Bio. Med.7(2), 242–247 (2011).
   PubMed Web of Science ®Google Scholar
• Chandran S , RoyA , SahaRN. Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note. AAPS Pharm. Sci. Tech.9, 1031–1037 (2008).
   PubMed Web of Science ®Google Scholar
• Date AA , PatravaleVB. Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interface Sci.9, 222–235 (2004).
   Web of Science ®Google Scholar
• Shetiya P , VidyadharaS , RamuA , SasidharRL , ViswanadhK. Development and characterization of a novel nanosuspension based drug delivery system of valsartan: a poorly soluble drug. Asian J. Pharm.9, 9–34 (2015).
   Google Scholar
• Zhang J , XieZ , ZhangN , ZhongJ. Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application. Nanostructures Drug Deliv.413–443 (2017).
   Google Scholar
• Sinha B , MullerRH , MoschwitzerJP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int. J. Pharm.453, 126–141 (2013).
   PubMed Web of Science ®Google Scholar
• Bujanakova Z , DutkovaE , BalazM , TurianicovaE , BalazP. Stability studies of As4S4 nanosuspension prepared by wet milling in poloxamer 407. Int. J. Pharm.478, 187–192 (2015).
   PubMedGoogle Scholar
• Ravichandran R . Development of an oral curcumin nanocrystal formulation. J. Nanotechnol. Eng. Med.3(4), 041007 (2013).
   Google Scholar
• Khan MI , MadniA , PeltonenL. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur. J. Pharm. Sci.95, 88–95 (2016).
   PubMed Web of Science ®Google Scholar
• Muller RH , PetersK. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm.160, 229–237 (1998).
   Web of Science ®Google Scholar
• Rabinow BE . Nanosuspensions in drug delivery. Nature Rev. Drug. Disc.3, 785–796 (2004).
   PubMed Web of Science ®Google Scholar
• Lee ES , NaK , BaeYH. Super pH sensitive multifunctional polymeric micelle. Nano Lett.5, 325–329 (2005).
   PubMed Web of Science ®Google Scholar
• Sofie V , JanV , LudoF , PatrickA. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze drying of drug nanosuspensions–a case study with itraconazole. Eur. J. Pharm. Biopharm.70, 590–596 (2008).
   PubMed Web of Science ®Google Scholar
• Onoue S , TakahashiH , KawabataYet al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J. Pharm. Sci.99, 1871 (2010).
   PubMed Web of Science ®Google Scholar
• Kumar MP , RaoYM , ApteS. Formulation of nanosuspensions of albendazole for oral administration. Curr. Nanosci.4, 53–58 (2008).
   Web of Science ®Google Scholar
• DeWaard H , HinrichsW , FrijlinkH. A novel bottom–up process to produce drug nanocrystals: controlled crystallization during freeze drying. J. Control. Rel.128(2), 179–183 (2008).
   PubMed Web of Science ®Google Scholar
• Nadia M , DaliaG , HananR , HodaT. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int. J. Pharm.506, 57–67 (2016).
   PubMedGoogle Scholar